Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies
暂无分享，去创建一个
A. Alfranca | R. Colomer | A. Ramos-Leví | M. Adrados | P. Gullón | R. Arranz | N. Romero-Laorden | R. Mondéjar | J. Rogado | A. Ballesteros | V. Pacheco-Barcia | J. Aspa | O. Donnay | J. M. Serra López-Matencio | J. Sanchez-Torres | A. Lorenzo | A. Garrido | P. Costas | José M. Serra López-Matencio